Effects of adipogenic conditions on the in vitro growth of human hematopoietic stem and progenitor cells from umbilical cord blood

2014 ◽  
Vol 42 (8) ◽  
pp. S53
Author(s):  
Angelica Muñiz-Rivera-Cambas ◽  
Patricia Flores-Guzman ◽  
Hector Mayani
Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 4039-4039
Author(s):  
Ri Zhang ◽  
Wenjin Gao ◽  
Yuanyuan Sun ◽  
Jingcheng Miao ◽  
Xueguang Zhang

Abstract Transforming growth factor-beta 1 (TGF-β1) is known to maintain primitive human hematopoietic stem/progenitor cells with polyfunctional role in a quiescent state and CD133 is a new stem cell antigen that may provide an alternative to CD34 for the selection and expansion of hematopoietic cells for transplantation. To investigate the specific effect of TGF-β1 on proliferation and differentiation of CD133 positive cells derived from umbilical cord blood (UCB) during short-term culture in vitro, CD133 positive cells from 20 fresh UCB samples were selected using Miltenyi Biotec’s CliniMACS separation device and were cultured in IMDM medium with 20% FCS in the presence of a cytokine combination of SCF, IL-6, thrombopoietin, IL-3 and Flt3-ligand for up to 2 weeks and TGF-β1 with low concentration was also added to the mediumon day 4. The proliferative response was assessed at day 7, day 10 and day 14 by evaluating the following parameters: nucleated cells (NC), clonogenic progenitors (CFU-GEMM,CFU-GM and BFU-E), and immunophenotypes (CD133 and CD34). The results showed that efficacious expansion of various hematopoietic stem/progenitor cells was constantly observed during the culture. The fold expansion of NC on day7, day10 and day14 expansion were 33.59,224.26 and 613.48, respectively. The fold expansion of CFU-GEMM, CFU-GM and BFU-E on day 10 were 24.89, 41.62 and 49.28, respectively, obviously higher than that without ex vivo expansion (P<0.05). The expansions of CD133+, CD133+CD34+ and CD34+ subpopulation on day 14 were up to 25.83-fold, 16.16-fold and 60.54-fold, respectively. Furthermore the expansion systems with TGF-β1 showed more CD133+ cells than control at every time points. Our datas suggested that the CD133+ cells from human UCB have great expansion potential for ex-vivo expansion. The low concentration of TGF-β1 may delay over-differentiation of hematopoietic stem/progenitor cells.


Cytotherapy ◽  
2006 ◽  
Vol 8 (3) ◽  
pp. 265-276 ◽  
Author(s):  
T.P.H. Meyer ◽  
B. Hofmann ◽  
J. Zaisserer ◽  
V.R. Jacobs ◽  
B. Fuchs ◽  
...  

2015 ◽  
Vol 24 (1) ◽  
pp. 97-113 ◽  
Author(s):  
Ryusuke Nakatsuka ◽  
Yoshikazu Matsuoka ◽  
Yasushi Uemura ◽  
Keisuke Sumide ◽  
Ryuji Iwaki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document